RadImmune Therapeutics, Inc. — Form D

RadImmune Therapeutics, Inc. of TARRYTOWN, NY, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-22. The offering totals $21.8M, of which $13.6M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2019-08-22
• Form: D
• Accession: 0001785686-19-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $21.8M
• Amount sold: $13.6M
• Remaining: $8.2M
• Minimum investment: $1
• Investors: 14
• Date of first sale: 2019-08-02
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-347151

Issuer

• Name: RadImmune Therapeutics, Inc.
• CIK: 0001785686
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2016
• Address: 303 SOUTH BROADWAY, SUITE 105, TARRYTOWN, NY, 10591
• Phone: (914) 332-5393

Officers, directors & promoters (4)

More

• CIK 1785686 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search